$6.83
-0.0100-0.15%
Pre-Market: 8:06 AM EDT
15 minutes delayed
Comments
Loading...
Recursion Pharmaceuticals (RXRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Quotes, Forecast and News Summary
Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Recursion Pharmaceuticals (RXRX) stock?
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Who are Recursion Pharmaceuticals (RXRX) competitors?
Other companies in Recursion Pharmaceuticals’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), SpringWorks Therapeutics (NASDAQ:SWTX), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Arrowhead Pharma (NASDAQ:ARWR).
What is the forecast, or price target, for Recursion Pharmaceuticals (RXRX) stock?
Recursion Pharmaceuticals has a consensus price target of $12.00.
What is the current price for Recursion Pharmaceuticals (RXRX)?
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $6.83 last updated September 25, 2024 at 8:06 AM EDT.
Does Recursion Pharmaceuticals (RXRX) pay a dividend?
There are no upcoming dividends for Recursion Pharmaceuticals.
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Recursion Pharmaceuticals (RXRX) going to split?
There is no upcoming split for Recursion Pharmaceuticals.
What sector and industry does Recursion Pharmaceuticals (RXRX) operate in?
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.